The King Lab (some assembly required)

Dept. of Biochemistry
Institute for Protein Design
University of Washington

Commercial Science Activities

Neil is a co-founder and chair of the scientific advisory board of Icosavax, Inc., a biotechnology company founded in 2017 that is developing nanoparticle vaccines for infectious disease. Icosavax has licensed IP from the UW on which Neil is a co-inventor. He also has an consulting agreement with Icosavax.

Updated 4/1/19.